In Australia, gout is one of the most common forms of inflammatory arthritis that affects adults, with self-reported prevalence rates of up to 6.8%. It is a lifelong condition that primarily causes acute monoarthritis. It is associated with an increased risk of joint damage and deformity, kidney and heart disease. Aetiology includes genetic factors, chronic kidney disease and obesity.
Gout Treatment Algorithm: optimise patient care
My Gout Plan: a plan for patients to record medicines, doses and serum urate levels
Gout and Diet: fact sheet about gout and diet for patients
Webinar: case-based insights on gout care. Watch Beyond the Pain: Best Practice Approach to Managing Gout
Differential diagnosis for gout includes septic arthritis and pseudogout. All of these conditions can have a similar clinical presentation.
Joint aspiration: only way to achieve a definitive diagnosis. Request cell count, microbiology (MCS), and crystal analysis.
Dual Energy CT: visualises uric acid and calcium deposits. It is not considered a tool for routine diagnosis, especially in early disease state.
X-Ray: useful to identify joint damage but not monosodium urate crystals.
Serum urate: levels may be falsely low during an acute flare so should not be solely relied on to make a diagnosis of gout.
For detailed guidance, refer to the Gout Treatment Algorithm.
NSAIDs: consider contraindications and precautions - generally preferred in younger patients.
OR
Prednisolone/prednisone: 15-30 mg orally daily for 3-5 days or intra-articular methylprednisolone if ≤2 joints are affected and reduced systemic absorption desired.
Treat-to-target: aim for <0.36 mmol/L for non tophaceous gout, and <0.30 mmol/L if tophi, gouty arthritis or recurrent attacks are present.
Monitor serum urate concentration, renal, and liver function monthly until target levels are reached.
|
![]() |
Main risk factors for gout are genetic predisposition, impaired kidney function and obesity.
Diet and alcohol intake are no longer thought to play as big a role.
Diet: some foods and beverages may trigger flares but are not the cause of gout. Advise patients to reduce consumption rather than eliminate their intake of alcohol, animal based foods high in purine (i.e. shellfish, fish, red meat) and sugary drinks high in fructose.
Eat a balanced diet and maintain adequate hydration.
After reading the clinical summary above and reviewing the references, complete the quiz to gain 30 minutes of EA CPD and 30 minutes of RP CPD.
You can either self-report CPD to your CPD home, or Medcast will track your learning via your personal CPD Tracker and you can download and report these points once a year. See our CPD Tracker FAQ.
Please log in or sign up for a free Medcast account to access the case study questions and achieve the CPD credits.
The Quality Use of Medicines Alliance a consortium of eight health and consumer organisations, will align their work across the two grants, awarded under the Australian Government’s Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program.
Erectile dysfunction is more than a social problem - it’s associated with significant morbidity, including cardiovascular disease, diabetes, and benign prostate hyperplasia. This FastTrack activity takes you through the risk factors, assessment and management of erectile dysfunction. Earn RP and EA CPD with completion of the quiz.
Osteoporosis is a significant health issue, affecting millions of Australians over the age of 50. Appropriate screening for at-risk patients is the first step in reducing the risk of minimal trauma fractures. This FastTrack activity discusses the application of DXA scanning as well as pharmacological and non-pharmacological interventions for osteoporosis. Complete the quiz to receive RP and EA CPD.
This is the second FastTrack on atrial fibrillation (AF). Part 1 described the diagnosis, initial assessment of AF, and indications for urgent review. This FastTrack describes the approach to setting a management strategy using risk calculators, how to assess and reduce risk factors, and long term monitoring of patients with AF.